Ex Vivo Detection and Analysis of Non-inducible Latent HIV
非诱导性潜伏 HIV 的离体检测和分析
基本信息
- 批准号:9046237
- 负责人:
- 金额:$ 23.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-12-01 至 2017-11-30
- 项目状态:已结题
- 来源:
- 关键词:AbateAddressAntigensBiological AssayCD4 Positive T LymphocytesCell CountCell DensityCell FractionCell LineageCell ProliferationCell SeparationCellsChromosomesConsensusCytolysisDNADNA MethylationDetectionDevelopmentEnvironmentFrequenciesGene ExpressionGenesGenetic TranscriptionGenomeGoldHIVHIV InfectionsImmune systemIn VitroIndividualInterleukin-2LaboratoriesLatent VirusMetabolismMethodologyMethodsPeripheral Blood Mononuclear CellPhasePopulationProceduresProductionPropertyProtocols documentationProvirusesRNAReadingRegimenResidual stateResourcesRestSamplingShockSignal TransductionStructureT-LymphocyteTechnologyTestingTimeTranscriptViralViral ProteinsVirusVirus ActivationVirus IntegrationVirus Latencybisulfite sequencingin vivointegration sitekillingsmethylation patternnovelnovel strategiespreventprotein expressionpublic health relevancesingle cell analysisstandard measureviral DNAwhole genome
项目摘要
DESCRIPTION (provided by applicant): No current methods are able to efficiently "shock" cells into producing virus from latent HIV reservoirs, a prerequisite for killing antigen positive cells by the immune system. Understanding the mechanisms that hinder the induction of proviruses out of latency is critical to latency reversal and to reservoir depletion. We propose to
identify at least some of these mechanisms through development and implementation of a new approach to defining properties of latently infected cells. In the R21 phase of the proposed studies we will develop an experimental pipeline that will enable isolation and >1,000-fold expansion of cells harboring a single inducible or a non-inducible provirus at a purity of at least
1% (compared to ~0.001% in unfractionated PBMC populations). We will then define the structure of these proviruses by a multilocus qPCR screen followed by complete provirus sequencing to determine the potential for encoding infectious virus. This procedure will also reveal the proviral integration sites in host chromosomes and presence of episomal, circular viral DNA. In the R33 phase, we will distinguish between inducible and non-inducible proviruses using virus outgrowth assays and will attempt to use the expanded cell populations for isolation of pure, latently infected cells using PCR-activated cell sorting. In addition, we will further develop our new approach to reservoir characterization by performing multiple simultaneous downstream analyses of the aforementioned expanded cell lineages and purified cell populations harboring inducible and non-inducible proviruses. These will include transcriptional activity of the provirus and adjacent cellular genes, viral protein production and DNA methylation patterns. These studies are likely to reveal mechanisms preventing viral induction from latency. In addition, by expanding and identifying cell populations harboring individual inducible and non-inducible proviruses we will also provide a valuable resource for ex vivo testing means of inducing proviruses out of latency.
描述(由申请人提供):目前没有方法能够有效地“休克”细胞,使其从潜伏的HIV储库中产生病毒,这是免疫系统杀死抗原阳性细胞的先决条件。了解阻碍前病毒诱导出潜伏期的机制对潜伏期逆转和水库枯竭至关重要。我们建议
通过开发和实施定义潜伏感染细胞特性的新方法来识别这些机制中的至少一些。在拟议研究的R21阶段,我们将开发一个实验管道,该管道将能够分离和>1,000倍扩增携带单个诱导型或非诱导型前病毒的细胞,纯度至少为
1%(相比之下,未分级PBMC群体中约为0.001%)。然后,我们将通过多位点qPCR筛选确定这些前病毒的结构,然后进行完整的前病毒测序,以确定编码感染性病毒的潜力。该程序还将揭示宿主染色体中的前病毒整合位点和附加型环状病毒DNA的存在。在R33阶段,我们将使用病毒生长测定区分诱导型和非诱导型前病毒,并将尝试使用扩增的细胞群使用PCR激活的细胞分选分离纯的潜伏感染细胞。此外,我们将通过对上述扩增的细胞谱系和含有诱导型和非诱导型前病毒的纯化细胞群进行多重同时下游分析,进一步开发我们的储库表征新方法。这些将包括前病毒和邻近细胞基因的转录活性、病毒蛋白质产生和DNA甲基化模式。这些研究可能揭示防止病毒诱导潜伏的机制。此外,通过扩增和鉴定携带单个诱导型和非诱导型前病毒的细胞群,我们还将为诱导前病毒脱离潜伏期的离体测试手段提供有价值的资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES Ivan MULLINS其他文献
JAMES Ivan MULLINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES Ivan MULLINS', 18)}}的其他基金
Ex Vivo Detection and Analysis of Non-inducible Latent HIV
非诱导性潜伏 HIV 的离体检测和分析
- 批准号:
9187886 - 财政年份:2015
- 资助金额:
$ 23.64万 - 项目类别:
Mechanisms of Formation and Persistence of Active HIV Reservoirs
活性 HIV 病毒库的形成和持续机制
- 批准号:
8705776 - 财政年份:2014
- 资助金额:
$ 23.64万 - 项目类别:
Mechanisms of Formation and Persistence of Active HIV Reservoirs
活跃HIV病毒库的形成和持续机制
- 批准号:
9229518 - 财政年份:2014
- 资助金额:
$ 23.64万 - 项目类别:
IMMUNOLOGICAL AND VIROLOGICAL EVENTS IN EARLY HIV INFECTION
HIV 感染早期的免疫学和病毒学事件
- 批准号:
7842962 - 财政年份:2010
- 资助金额:
$ 23.64万 - 项目类别:
Management and Retrieval of Multidisciplinary HIV Research Data
多学科 HIV 研究数据的管理和检索
- 批准号:
8019466 - 财政年份:2010
- 资助金额:
$ 23.64万 - 项目类别:
IMMUNOLOGICAL AND VIROLOGICAL EVENTS IN EARLY HIV INFECTION
HIV 感染早期的免疫学和病毒学事件
- 批准号:
8508162 - 财政年份:2010
- 资助金额:
$ 23.64万 - 项目类别:
IMMUNOLOGICAL AND VIROLOGICAL EVENTS IN EARLY HIV INFECTION
HIV 感染早期的免疫学和病毒学事件
- 批准号:
8691648 - 财政年份:2010
- 资助金额:
$ 23.64万 - 项目类别:
Management and Retrieval of Multidisciplinary HIV Research Data
多学科 HIV 研究数据的管理和检索
- 批准号:
7840648 - 财政年份:2010
- 资助金额:
$ 23.64万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.64万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.64万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.64万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.64万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.64万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.64万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.64万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.64万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.64万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.64万 - 项目类别:
Research Grant